Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer

Journal of Molecular Histology

Volumn 43, Issue 6, 2012, Pages 715-721

  Zhang, Jinfeng ^a   Ning, Jinfeng ^a   Geng, Jingshu ^a   Cui, Binbin ^a   Dong, Xinshu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Colon cancer; Human; Prognosis; Tumor suppressor in lung cancer 1

Indexed keywords

MESSENGER RNA; TUMOR SUPPRESSOR IN LUNG CANCER 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CADM1 PROTEIN, HUMAN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENDER; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR IN LUNG CANCER 1 GENE; WESTERN BLOTTING; COLON TUMOR; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL ADHESION MOLECULES; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84877103211     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-012-9438-7     Document Type: Article

References (25)

1. Ando K, Ohira M, Ozaki T, Nakagawa A, Akazawa K, Suenaga Y, Nakamura Y, Koda T, Kamijo T, Murakami Y, Nakagawara A (2008) Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation. Int J Cancer 123(9):2087-2094. doi: 10.1002/ijc.23776
2. Chen K, Wang G, Peng L, Liu S, Fu X, Zhou Y, Yu H, Li A, Li J, Zhang S, Bai Y, Zhang Y (2011) CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease. Int J Cancer 128(2):266-273. doi: 10.1002/ijc.25356
3. Chen D, Zhang Y, Zhang X, Li J, Han B, Liu S, Wang L, Ling Y, Mao S, Wang X (2012) Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes. Acta Histochem. doi: 10.1016/j.acthis.2012.05.004
4. Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y (2003) Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer 107(1):53-59. doi: 10.1002/ijc.11348 (Pubitemid 37100085)
5. Goto A, Niki T, Chi-Pin L, Matsubara D, Murakami Y, Funata N, Fukayama M (2005) Loss of TSLC1 expression in lung adenocarcinoma: relationships with histological subtypes, sex and prognostic significance. Cancer Sci 96(8):480-486. doi: 10.1111/j.1349-7006.2005.00075.x (Pubitemid 41387300)
6. Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM, Kandioler D, Berger W, Stiglbauer W, Depisch D, Pirker R, Zielinski CC, Zochbauer-Muller S (2007) Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat 103(3):283-291. doi: 10.1007/s10549-006-9377-7 (Pubitemid 46944509)
7. Hong Y, Downey T, Eu KW, Koh PK, Cheah PY (2010) A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 27(2):83-90. doi: 10.1007/s10585-010-9305-4
8. Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP (2003) Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Mol Carcinog 38(4):170-178. doi: 10.1002/mc.10156 (Pubitemid 37523709)
9. Ito T, Shimada Y, Hashimoto Y, Kaganoi J, Kan T, Watanabe G, Murakami Y, Imamura M (2003) Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 63(19):6320-6326 (Pubitemid 37255179)
10. Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, Hruban R, Offerhaus JG, Goggins M (2002) Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Cancer Biol Ther 1(3):293-296
11. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90. doi: 10.3322/caac.20107
12. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH, Murakami Y (2001) TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 27(4):427-430. doi: 10.1038/86934 (Pubitemid 32268425)
13. Liang QL, Chen GQ, Li ZY, Wang BR (2011) Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest 29(2):107-112
14. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408. doi: 10.1006/meth.2001.1262 (Pubitemid 34164012)
15. Lung HL, Cheung AK, Xie D, Cheng Y, Kwong FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI, Zabarovsky ER, Tsao SW, Stanbridge EJ, Lung ML (2006) TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res 66(19):9385-9392. doi: 10.1158/0008-5472.CAN-06-0590 (Pubitemid 44623634)
16. Masuda M, Yageta M, Fukuhara H, Kuramochi M, Maruyama T, Nomoto A, Murakami Y (2002) The tumor suppressor protein TSLC1 is involved in cell-cell adhesion. J Biol Chem 277(34):31014-31019. doi: 10.1074/jbc.M203620200 (Pubitemid 34970805)
17. Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T (2010) Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma. Oncogene 29(18):2681-2690. doi: 10.1038/onc.2010.22
18. Punt CJ, Tol J (2009) More is less: combining targeted therapies in metastatic colorectal cancer. Nat Rev Clin Oncol 6(12):731-733. doi: 10.1038/nrclinonc.2009.168
19. Sobin LH, Fleming ID (1997) TNM Classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80(9):1803-1804. doi: 10.1002/(SICI)1097- 0142(19971101)80:9<1803
20. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ (2004) TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 96(4):294-305 (Pubitemid 38256274)
21. Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, Sakurai-Yageta M, Ito A, Goto A, Saito M, Kasumi F, Murakami Y (2012) Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer. Breast Cancer. 19(3):242-252. doi: 10.1007/s12282-011-0272-7
22. Yang YX, Yang AH, Yang ZJ, Wang ZR, Xia XH (2006) Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis. Int J Gynecol Cancer 16(5):1868-1872. doi: 10.1111/j.1525-1438.2006.00656.x (Pubitemid 44470048)
23. Yang G, He W, Cai M, Luo F, Kung H, Guan X, Zeng Y, Xie D (2011) Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma. Int J Gynecol Cancer 21(3):486-493. doi: 10.1097/IGC. 0b013e31820fa168
24. Yang W, Cui S, Ma J, Lu Q, Kong C, Liu T, Sun Z (2012) Cigarette smoking extract causes hypermethylation and inactivation of WWOX gene in T-24 human bladder cancer cells. Neoplasma 59(2):216-223
25. You Y, Ma L, You M, Li X, Wang S, Li H, Wu D, Yang H, Li ZY (2010) TSLC1 gene silencing in cutaneous melanoma. Melanoma Res 20(3):179-183. doi: 10.1097/CMR.0b013e32833413c0